Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Nov 28, 2018 2:47am
60 Views
Post# 29031464

RE:COMING SOON

RE:COMING SOONLooks like you've been smoking way too much of the product here.  LOL

There is no way in heck that sales will hit anywhere close to the $4B mark for any of the weed companies by the end of 2019.  In fact, I would be surprised if legal weed sales hits your $4B mark for the entire sector as a whole by the end of the 2019 fiscal year.

Take a look at Canopy who has already gone through 2 quarters of their 2019 fiscal year and they have sold only less than $50M to this point in time.  Even with Aurora doing much better at something like $35M in total proforma sales for their first quarter, there is absolutely no way that any of these companies will hit the $500M mark for this year, let alone be at $4B by year end.

Total crazy talk here, especially when you consider the fact that these companies don't even have their supply chain in place yet as clearly evident by the empty store shelves and multi-day closures which the stores are going through due to having no product available for sale.

Guess what, if you can't get your product to market, your sales will not amount to very much.

ACBMADEMERICH wrote: What will the sahre price be when sales hits $4 Billion. We should be there by the end of 2019. Are you patient enough to wait until then. I am!!


Bullboard Posts